Restrained Complexing Agent Synthesis for High-Yield 18F Labeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The laborious and low-yield synthesis of restrained complexing agents (RESCA) for 18F labeling is a barrier to their widespread development and use in PET imaging, particularly due to incompatible conjugation conditions and inefficient linker methods.

Innovation Solution

A novel synthesis method involving multiple reaction steps with specific solvents, reducing agents, and bases, including the use of NaBH(OAc)3 and DIPEA, reduces the number of steps and eliminates the need for palladium catalysts, enhancing yield and purity, and allowing for large-scale production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional complexing agents (EDTA, NTA) are used to sequester metal ions, then metal ion sequestration is achieved, but bacterial growth is promoted and treatment time is extended

Engineering Contradiction:
Improvemetal ion sequestration effectivenessVSAvoidbacterial growth promotion
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent modifies the molecular structure of conventional complexing agents by introducing restrained amine groups with specific pKa values (5.5-7.5 for primary/secondary amines, 3.0-5.0 for tertiary amines). This parameter change in the chemical structure alters the pH-dependent complexation behavior, allowing effective metal ion binding while preventing bacterial growth promotion that occurs with traditional agents like EDTA and NTA.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If conventional complexing agents are used, then metal ions are bound, but treatment time is excessively long

Engineering Contradiction:
Improvemetal ion binding capabilityVSAvoidtreatment time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The restrained complexing agents feature modified basicity parameters (pKa values) that optimize the kinetics of metal ion complexation. The specific pKa ranges create favorable thermodynamic and kinetic conditions for rapid metal binding at treatment pH levels, significantly reducing the time required to achieve effective metal ion sequestration compared to conventional agents.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If pH is increased to improve metal ion binding, then binding effectiveness improves, but bacterial growth is further promoted

Engineering Contradiction:
Improvemetal ion binding effectivenessVSAvoidbacterial growth promotion
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent fundamentally changes the pH-dependence profile of the complexing agent through structural modification. The restrained amine groups provide optimal metal ion binding effectiveness at lower pH levels (where bacterial growth is suppressed) rather than requiring high pH conditions. This parameter change in the binding mechanism allows simultaneous achievement of effective metal sequestration and bacterial growth inhibition.

Inventive Principle:
Principle #35Parameter changes

4Reliability

If conventional complexing agents are used, then metal ions are sequestered, but sludge production increases

Engineering Contradiction:
Improvemetal ion sequestrationVSAvoidsludge production
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The modified complexing agents form more stable and soluble metal complexes due to the restrained amine group structure and optimized pKa values. This parameter change in complex stability prevents precipitation and sludge formation that occurs with conventional agents, allowing effective metal ion sequestration to be maintained while minimizing solid waste generation.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The improved method achieves high yields and purities of RESCA compounds, facilitating their use in PET imaging applications by providing efficient and cost-effective synthesis.

Implementation Method 1

restrained complexing agents having formula (I) and processes for their synthesis wherein a compound of formula (II)... is condensed with a compound of formula (III)... to give the restrained complexing agent of formula (I)

Methodology Applied
Scientific EffectComplexation:

Data Source

PatentEP4423056B1Synthesis of restrained complexing agents
Publication Date: 2026.05.06 GENENTECH INC
  • EP4423056B1 patent drawingFigure 1
  • EP4423056B1 patent drawingFigure 2
  • EP4423056B1 patent drawingFigure 3

AI summary

Improved methods of synthesis of a restrained complexing agent are described herein. Compounds, including salts and solvates thereof, and compositions relevant to the improved methods are also described.